222 BERKELEY STREET, BOSTON, MA
Market cap: $6.9B (2/09/2026)
Price: $102.87
Investor Presentation
Director Resignation - Camille L. Bedrosian Steps Down from Board
Reports Third Quarter 2025 Financial Results and Business Update
Reports Second Quarter 2025 Financial Results and Business Update
News, Underwriting Agreement, Legal Opinion
Positive Topline Results from Phase 2 Trial Evaluating Oral MC4R Agonist Bivamelagon in Patients with Acquired Hypothalamic Obesity
Q3
Q2
Q1
FY 2023
Q2 amended
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities